View Older Stories View More Recent Stories

Feb 28, 2022 08:00AM Pliant Therapeutics Inc. (PLRX) Reports Positive Data from Expanded Phase 1b BAL Trial of PLN-74809 Demonstrated Suppression of TGF-β Signaling in Healthy Volunteers
Feb 28, 2022 08:00AM Pliant Therapeutics Announces Positive Data from Expanded Phase 1b BAL Trial of PLN-74809 Demonstrated Suppression of TGF-β Signaling in Healthy Volunteers
Feb 28, 2022 08:00AM Pliant Therapeutics Announces Positive Data from Expanded Phase 1b BAL Trial of PLN-74809 Demonstrated Suppression of TGF-β Signaling in Healthy Volunteers
Feb 24, 2022 05:41PM Pliant Therapeutics Inc. (PLRX) Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in IPF
Feb 24, 2022 05:41PM Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis
Feb 24, 2022 05:41PM Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis
Feb 24, 2022 08:03AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Feb 24, 2022 08:03AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Jan 11, 2022 08:04AM Pliant Therapeutics Inc. (PLRX) Announces Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones
Jan 11, 2022 08:03AM Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones
Jan 11, 2022 08:03AM Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones
Dec 21, 2021 08:06AM Pliant Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Dec 21, 2021 08:06AM Pliant Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Nov 18, 2021 08:00AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Nov 18, 2021 08:00AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Nov 9, 2021 04:06PM Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Nov 9, 2021 04:06PM Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Oct 7, 2021 08:06AM Pliant Therapeutics to Participate in Piper Sandler Lung Day
Oct 7, 2021 08:06AM Pliant Therapeutics to Participate in Piper Sandler Lung Day
Sep 7, 2021 07:02AM Pliant Therapeutics Inc. (PLRX) Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis
Sep 7, 2021 07:00AM Pliant Therapeutics Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis
Sep 7, 2021 07:00AM Pliant Therapeutics Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis
Sep 3, 2021 04:10PM Pliant Therapeutics Announces Webcast to Present Interim Clinical Data from Ongoing Phase 2a PET Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis
Sep 3, 2021 04:10PM Pliant Therapeutics Announces Webcast to Present Interim Clinical Data from Ongoing Phase 2a PET Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis
Sep 2, 2021 08:00AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Sep 2, 2021 08:00AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Aug 9, 2021 04:05PM Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Aug 9, 2021 04:05PM Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Aug 3, 2021 08:00AM Pliant Therapeutics to Participate in the BTIG Biotechnology Conference
Aug 3, 2021 08:00AM Pliant Therapeutics to Participate in the BTIG Biotechnology Conference
May 10, 2021 04:21PM Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 10, 2021 04:21PM Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 5, 2021 08:05AM Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May 5, 2021 08:05AM Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
Apr 5, 2021 08:00AM Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference
Apr 5, 2021 08:00AM Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference
Mar 16, 2021 04:05PM Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 16, 2021 04:05PM Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 16, 2021 08:05AM UPDATE: Pliant Therapeutics Inc. (PLRX) Reports Complete PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner
Mar 16, 2021 08:00AM Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner
Mar 16, 2021 08:00AM Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner
Feb 18, 2021 08:30AM Pliant Therapeutics to Participate in Upcoming Virtual Investor Events
Feb 18, 2021 08:30AM Pliant Therapeutics to Participate in Upcoming Virtual Investor Events
Jan 12, 2021 08:06AM Pliant Therapeutics Inc. (PLRX) Adds David Pyott to Board
Jan 12, 2021 08:00AM Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors
Jan 12, 2021 08:00AM Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors
Jan 4, 2021 08:00AM Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF
Jan 4, 2021 08:00AM Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF
Nov 19, 2020 08:00AM Pliant Therapeutics To Participate In The Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 10, 2020 04:05PM Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
View More Recent Stories View Older Stories